Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

BACKGROUND: High costs of direct-acting antivirals (DAAs) have led health-care insurers to limit access worldwide. Using a natural experiment, we evaluated the impact of removing fibrosis stage restrictions on hepatitis C (HCV) treatment initiation rates among people living with human immunodeficien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Saeed, Sahar, Strumpf, Erin, Moodie, Erica E M, Wong, Leo, Cox, Joseph, Walmsley, Sharon, Tyndall, Mark, Cooper, Curtis, Conway, Brian, Hull, Mark, Martel-Laferriere, Valerie, Gill, John, Wong, Alexander, Vachon, Marie-Louise, Klein, Marina B
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7353326/
https://ncbi.nlm.nih.gov/pubmed/31504327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados